Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Kistamás Kornél

University of Debrecen Faculty of Medicine

Department of Physiology

2010-

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2011-2026

2026

Vaiciuleviciute, R., Alaburda, A., Uzielienè, I., Kistamás, K., Lengyel, M., Dinnyés, A., Bergaud, C., Bernotiene, E.: Biomimetic electrospun scaffolds for engineered heart tissue: from design parameters to drug testing platforms.
Front. Bioeng. Biotechnol. 14, 1-26, (article identifier: 1711698), 2026.

doi DEA

Journal metrics:

Q1 Bioengineering (2025)

Q1 Biomedical Engineering (2025)

Q1 Biotechnology (2025)

Q1 Histology (2025)

2022

Molnárné Vasas, N., Pénzes, Z., Kistamás, K., Nánási, P. P., Molnár, S., Szegedi, A., Szöllősi, A. G., Bíró, T.: Transient Receptor Potential Vanilloid 3 Expression Is Increased In Non-Lesional Skin Of Atopic Dermatitis Patients.
Exp. Dermatol. 31 (5), 807-813, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

2021

Horváth, B., Khan, M. N., Hézső, T., Dienes, C., Kovács, Z. M., Kiss, D. Z., Prorok, J., Árpádffy-Lovas, T., Varga, R., Fujii, E., Topal, L., Kistamás, K., Varró, A., Virág, L.: Is selective late sodium current inhibition different from class I/B antiarrhythmic action? Comparison of the effects of GS967 to mexiletine in canine ventricular myocardium.
Europace. 23 (Supplement), iii622, (article identifier: 116), 2021.

doi DEA

Kistamás, K., Hézső, T., Horváth, B., Nánási, P. P.: Late sodium current and calcium homeostasis in arrhythmogenesis.
Channels. 15 (1), 1-19, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Biophysics

Q2 Medicine (miscellaneous)

Hézső, T., Naveed, M., Dienes, C., Kiss, D. Z., Prorok, J., Árpádffy-Lovas, T., Varga, R., Fujii, E., Mercan, T., Topal, L., Kistamás, K., Szentandrássy, N., Almássy, J., Jost, N., Magyar, J., Bányász, T., Baczkó, I., Varró, A., Nánási, P. P., Virág, L., Horváth, B.: Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium.
Sci. Rep. 11, 9565, (article identifier: 9565), 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

2020

Kistamás, K., Veress, R., Horváth, B., Bányász, T., Nánási, P. P., Eisner, D. A.: Calcium Handling Defects and Cardiac Arrhythmia Syndromes.
Front. Pharmacol. 11, 72, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

Nánási, P. P., Szabó, Z., Kistamás, K., Horváth, B., Virág, L., Jost, N., Bányász, T., Almássy, J., Varró, A.: Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing.
Prog. Biophys. Mol. Biol. 157, 76-83, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biophysics

Q3 Molecular Biology

Horváth, B., Hézső, T., Szentandrássy, N., Kistamás, K., Árpádffy-Lovas, T., Veress, R., Dienes, C., Baranyai, D., Virág, L., Nagy, N., Baczkó, I., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Late Sodium Current in Canine, Guinea Pig and Human Left Ventricular Myocardium.
Biophys. J. 118 (Suppl.), 494a-495a, 2020.

doi DEA WoS

Horváth, B., Hézső, T., Kiss, D. Z., Kistamás, K., Magyar, J., Nánási, P. P., Bányász, T.: Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.
Front. Pharmacol. 11, 1-17, (article identifier: 413), 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

10.

Horváth, B., Hézső, T., Szentandrássy, N., Kistamás, K., Árpádffy-Lovas, T., Varga, R., Gazdag, P., Veress, R., Dienes, C., Baranyai, D., Almássy, J., Virág, L., Nagy, N., Baczkó, I., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Late sodium current in human, canine and guinea pig ventricular myocardium.
J. Mol. Cell. Cardiol. 139, 14-23, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q2 Molecular Biology

2018

11.

Szöllősi, A. G., Molnárné Vasas, N., Angyal, Á., Kistamás, K., Nánási, P. P., Mihály, J., Béke, G., Lisztes, E., Szegedi, A., Kawada, N., Yanagida, T., Mori, T., Kemény, L., Bíró, T.: Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes.
J. Invest. Dermatol. 138 (2), 365-374, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Dermatology

Q1 Molecular Biology

12.

Horváth, B., Szentandrássy, N., Veress, R., Baranyai, D., Kistamás, K., Almássy, J., Tóth, A., Magyar, J., Bányász, T., Nánási, P. P.: Effect of the intracellular calcium concentration chelator BAPTA acetoxy-methylester on action potential duration in canine ventricular myocytes.
J. Physiol. Pharmacol. 69 (1), 99-107, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

13.

Drabik, G., Józsa, T., Ruzsnavszky, O., Kistamás, K., Dienes, B., Kovács, I., Benyó, M., Flaskó, T.: The role of appendix testis androgen receptor status in the hormonal treatment of undescended testis.
Andrology. 6 (Suppl.), 71-72, 2018.

DEA

14.

Veress, R., Baranyai, D., Hegyi, B., Kistamás, K., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Szentandrássy, N., Horváth, B.: Transient receptor potential melastatin 4 channel inhibitor 9-phenanthrol inhibits K+ but not Ca2+ currents in canine ventricular myocytes.
Can. J. Physiol. Pharmacol. 96 (10), 1022-1029, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

Q3 Physiology (medical)

2017

15.

Hegyi, B., Horváth, B., Váczi, K., Gönczi, M., Kistamás, K., Ruzsnavszky, F., Veress, R., Izu, L. T., Chen-Izu, Y., Bányász, T., Magyar, J., Csernoch, L., Nánási, P. P., Szentandrássy, N.: Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.
J. Mol. Cell. Cardiol. 109, 27-37, 2017.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Molecular Biology

16.

Magyar, J., Horváth, B., Váczi, K., Hegyi, B., Gönczi, M., Dienes, B., Kistamás, K., Bányász, T., Baczkó, I., Varró, A., Seprényi, G., Csernoch, L., Nánási, P. P., Szentandrássy, N.: Calcium Activated Chloride Current in Mammalian Ventricular Myocytes.
Biophys. J. 112 (3), 36a, 2017.

doi DEA WoS

17.

Szentandrássy, N., Hegyi, B., Horváth, B., Váczi, K., Gönczi, M., Dienes, B., Kistamás, K., Veress, R., Ruzsnavszky, F., Bányász, T., Magyar, J., Baczkó, I., Varró, A., Seprényi, G., Csernoch, L., Nánási, P. P.: Recent advances in research of cardiac calcium-activated chloride channels.
Acta Physiol. 221 (S713), 22, 2017.

DEA

2016

18.

Magyar, J., Kistamás, K., Váczi, K., Hegyi, B., Horváth, B., Bányász, T., Nánási, P. P., Szentandrássy, N.: Concept of relative variability of cardiac action potential duration and its test under various experimental conditions.
Gen. Physiol. Biophys. 35 (1), 55-62, 2016.

doi DEA

Journal metrics:

Q3 Biophysics

Q3 Medicine (miscellaneous)

Q4 Physiology

19.

Szentandrássy, N., Horváth, B., Váczi, K., Kistamás, K., Masuda, L., Magyar, J., Bányász, T., Papp, Z., Nánási, P. P.: Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes.
J. Physiol. Pharmacol. 67 (4), 483-489, 2016.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Physiology

20.

Pueyo, E., Dangerfield, C. E., Britton, O. J., Virág, L., Kistamás, K., Szentandrássy, N., Jost, N., Varró, A., Nánási, P. P., Burrage, K., Rodríguez, B.: Experimentally-Based Computational Investigation into Beat-To-Beat Variability in Ventricular Repolarization and Its Response to Ionic Current Inhibition.
PLoS One. 11 (3), e0151461, (article identifier: 0151461), 2016.

doi DEA WoS Scopus

Journal metrics:

Q1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

21.

Horváth, B., Váczi, K., Hegyi, B., Gönczi, M., Dienes, B., Kistamás, K., Bányász, T., Magyar, J., Baczkó, I., Varró, A., Seprényi, G., Csernoch, L., Nánási, P. P., Szentandrássy, N.: Sarcolemmal Ca2+-entry through L-type Ca2+ channels controls the profile of Ca2+-activated Cl- current in canine ventricular myocytes.
J. Mol. Cell. Cardiol. 97, 125-139, 2016.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Molecular Biology

2015

22.

Váczi, K., Hegyi, B., Ruzsnavszky, F., Kistamás, K., Horváth, B., Bányász, T., Nánási, P. P., Szentandrássy, N., Magyar, J.: 9-Anthracene carboxylic acid is more suitable than DIDS for characterization of calcium-activated chloride current during canine ventricular action potential.
Naunyn-Schmiedebergs Arch. Pharmacol. 388 (1), 87-100, 2015.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

23.

Kistamás, K., Szentandrássy, N., Hegyi, B., Váczi, K., Ruzsnavszky, F., Horváth, B., Bányász, T., Nánási, P. P., Magyar, J.: Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes.
J. Physiol. Pharmacol. 66 (1), 73-81, 2015.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Physiology

24.

Szentandrássy, N., Kistamás, K., Hegyi, B., Horváth, B., Ruzsnavszky, F., Váczi, K., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes.
Pflügers Arch. 467 (7), 1431-1443, 2015.

doi DEA

Journal metrics:

D1 Clinical Biochemistry

Q1 Physiology

Q1 Physiology (medical)

25.

Drabik, G., Józsa, T., Ruzsnavszky, O., Kistamás, K., Dienes, B., Kovács, I., Benyó, M., Flaskó, T.: Correlation between the androgen receptor status of the appendix testis and the efficacy of human chorionic gonadotropin treatment in undescended testis.
Int. Urol. Nephrol. 47 (8), 1235-1239, 2015.

doi DEA

Journal metrics:

Q3 Nephrology

Q2 Urology